1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Metastatic Prostate Cancer-Pipeline Insights, 2016

Metastatic Prostate Cancer-Pipeline Insights, 2016

  • November 2016
  • -
  • Delve Insight
  • -
  • 60 pages


DelveInsight’s, “ Metastatic Prostate Cancer-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Metastatic Prostate Cancer. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Metastatic Prostate Cancer. DelveInsight’s Report also assesses the Metastatic Prostate Cancer therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope
- The report provides competitivepipeline landscape of Metastatic Prostate Cancer
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Metastatic Prostate Cancer pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Metastatic Prostate Cancer and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Metastatic Prostate Cancer-Pipeline Insights, 2016

Illustrative Table of contents

- Metastatic Prostate Cancer Overview
- Metastatic Prostate Cancer Pipeline Therapeutics
- Metastatic Prostate Cancer Therapeutics under Development by Companies
- Metastatic Prostate Cancer Filed and Phase III Products
- Comparative Analysis
- Metastatic Prostate Cancer Phase II Products
- Comparative Analysis
- Metastatic Prostate Cancer Phase I and IND Filed Products
- Comparative Analysis
- Metastatic Prostate Cancer Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Metastatic Prostate Cancer - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Metastatic Prostate Cancer - Discontinued Products
- Metastatic Prostate Cancer - Dormant Products
- Companies Involved in Therapeutics Development for Metastatic Prostate Cancer
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Metastatic Prostate Cancer, 2016
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2016
- Comparative Analysis Phase II Products, 2016
- Comparative Analysis Phase I and IND Filed Products, 2016
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2016
- Drug Candidates Profiles
- Metastatic Prostate Cancer Assessment by Monotherapy Products
- Metastatic Prostate Cancer Assessment by Combination Products
- Metastatic Prostate Cancer Assessment by Route of Administration
- Metastatic Prostate Cancer Assessment by Stage and Route of Administration
- Metastatic Prostate Cancer Assessment by Molecule Type
- Metastatic Prostate Cancer Assessment by Stage and Molecule Type
- Metastatic Prostate Cancer Therapeutics - Discontinued Products
- Metastatic Prostate Cancer Therapeutics - Dormant Products
- Products under Development by Companies, 2016

List of Figures

- Number of Products under Development for Metastatic Prostate Cancer, 2016
- Filed and Phase III Products, 2016
- Phase II Products, 2016
- Phase I and IND Filed Products, 2016
- Discovery and Pre-Clinical Stage Products, 2016
- Metastatic Prostate Cancer Assessment by Monotherapy Products
- Metastatic Prostate Cancer Assessment by Combination Products
- Metastatic Prostate Cancer Assessment by Route of Administration
- Metastatic Prostate Cancer Assessment by Stage and Route of Administration
- Metastatic Prostate Cancer Assessment by Molecule Type
- Metastatic Prostate Cancer Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer: Analytical Tool

Prostate Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Epiomic Epidemiology Series: Prostate Cancer Forecast in 18 Major Markets 2016-2026

Epiomic Epidemiology Series: Prostate Cancer Forecast in 18 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • September 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Prostate Cancer in 18 Major Markets Prostate cancer is one of the most common cancers in men. The prostate, found only in men, is the ...

Prostate cancer- Market Insights, Epidemiology and Market Forecast-2023

Prostate cancer- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Prostate cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...


Download Unlimited Documents from Trusted Public Sources

Related Market Segments :

Prostate Cancer

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.